Application 216197

Type
ANDA
Sponsor
MARKSANS PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREGABALINPREGABALINCAPSULE;ORAL25MGNoNo
002PREGABALINPREGABALINCAPSULE;ORAL50MGNoNo
003PREGABALINPREGABALINCAPSULE;ORAL75MGNoNo
004PREGABALINPREGABALINCAPSULE;ORAL100MGNoNo
005PREGABALINPREGABALINCAPSULE;ORAL150MGNoNo
006PREGABALINPREGABALINCAPSULE;ORAL200MGNoNo
007PREGABALINPREGABALINCAPSULE;ORAL225MGNoNo
008PREGABALINPREGABALINCAPSULE;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25000-179PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-180PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-181PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-182PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-183PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-184PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-185PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent
25000-186PregabalinPregabalinMARKSANS PHARMA LIMITEDANDACurrent